China Resources Double-Crane Pharmaceutical(600062.SH): The compound polyethylene glycol(3350) electrolyte powder has obtained a drug registration certificate.

17:33 01/07/2026

China Resources Shuanghe (600062.SH) announced that recently, the company has received the Drug Registration Certificate for the compound polyethylene glycol (3350) electrolyte powder issued by the National Medical Products Administration. This approval is considered equivalent to passing consistency evaluation. This drug is used for the treatment of chronic constipation in children aged 1 to 11 years old; and for the treatment of fecal impaction in children aged 5 to 11 years old, specifically stubborn constipation accompanied by rectal and/or colonic fecal impaction.

China Resources Double-Crane Pharmaceutical (600062.SH) announced that the company recently received the Drug Registration Certificate for the compound polyethylene glycol (3350) electrolyte powder issued by the National Medical Products Administration. This approval is considered equivalent to passing consistency evaluation. The drug is used to treat chronic constipation in children aged 1 to 11 years old, and for the treatment of fecal impaction in children aged 5 to 11 years old, specifically stubborn constipation with rectal and/or colon fecal blockage.

NEUTECH GROUP(09616): Ruixin Cloud receives 8 million yuan capital injection from Rui Xin Health and Wang Xinghui.

NEUTECH GROUP (09616): Neutech Health, Neutech Cloud, and registered shareholders enter into variable equity entity agreements.

Midea Group Co., Ltd. (00300) used approximately 150 million yuan to repurchase 1,993,900 A shares on July 1st.

NEUTECH GROUP(09616): Ruixin Cloud receives 8 million yuan capital injection from Rui Xin Health and Wang Xinghui.

NEUTECH GROUP (09616): Neutech Health, Neutech Cloud, and registered shareholders enter into variable equity entity agreements.

Midea Group Co., Ltd. (00300) used approximately 150 million yuan to repurchase 1,993,900 A shares on July 1st.